CENTRAL EFFECTS OF MORPHINE, LEVORPHANOL, ( - )-METHADONE AND THE OPIOID-LIKE PEPTIDES BETA-ENDORPHIN AND D-ALANINE2-METHIONINE ENKEPHALINAMIDE ON URINE VOLUME OUTFLOW AND ELECTROLYTES
dc.contributor.author | HUIDOBROTORO, JP | |
dc.contributor.author | HUIDOBRO, F | |
dc.date.accessioned | 2025-01-23T19:44:18Z | |
dc.date.available | 2025-01-23T19:44:18Z | |
dc.date.issued | 1981 | |
dc.description.abstract | The intraventricular injection of 10-30 nmol of morphine, (-)-methadone or levorphanol caused a reduction in the volume of the urine output in rats previously hydrated with 0.5% NaCl. The decrease in urine outflow was associated with a dose-dependent reduction in the concentration of urine Na+ and K+. Two opioid-like peptides: .beta.-endorphin and D-alanine2 methionine enkephalinamide shared this morphine action. On a molar basis, .beta.-endorphin was about 100 times more potent than morphine to cause an equivalent antidiuresis. Naloxone injected i.p. antagonized the response of centrally administered morphine or .beta.-endorphin on urine formation and composition. (+)-Methadone or dextrorphan injected into the cerebral ventricles were considerably less active than their corresponding stereoisomers. N-methyl morphine injected i.p. was completely inactive up to doses that caused signs of toxicity; when injected into the lateral cerebral ventricles, it produced a decrease in the urine outflow and a reduction in the concentration of urine electrolytes. The pattern of changes in urine electrolytes produced by morphine and surrogates as well as the opioid-like peptides was in marked contrast to that caused by the i.p. administration of vasopressin. Whereas the i.p. administration of antidiuretic hormone caused oliguria and a large increase in the urine concentration of Na+ and K+, all the opiates produced at comparable antidiuresis a marked reduction in urine electrolytes. The opiates and the opioid-like peptides may selectively activate central opiate receptors to produce changes in urine formation and composition. Results are discussed in relation to probable central opiate mechanisms controlling the production and formation of urine. | |
dc.fuente.origen | WOS | |
dc.identifier.eissn | 1521-0103 | |
dc.identifier.issn | 0022-3565 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/100001 | |
dc.identifier.wosid | WOS:A1981LU32000008 | |
dc.issue.numero | 3 | |
dc.language.iso | en | |
dc.pagina.final | 585 | |
dc.pagina.inicio | 579 | |
dc.revista | Journal of pharmacology and experimental therapeutics | |
dc.rights | acceso restringido | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | CENTRAL EFFECTS OF MORPHINE, LEVORPHANOL, ( - )-METHADONE AND THE OPIOID-LIKE PEPTIDES BETA-ENDORPHIN AND D-ALANINE2-METHIONINE ENKEPHALINAMIDE ON URINE VOLUME OUTFLOW AND ELECTROLYTES | |
dc.type | artículo | |
dc.volumen | 217 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |